Scott T. Shearer
Keine laufenden Positionen mehr
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
James Shannon | M | 67 |
Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 1 Jahre |
Paul Sekhri | M | 66 |
Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 5 Jahre |
David Hoffmann | M | 79 | 26 Jahre | |
Bruce Cozadd | M | 60 | 11 Jahre | |
Peter Staple | M | 72 | 8 Jahre | |
Gary Patou | M | 65 |
Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 1 Jahre |
Ernest Mario | M | 85 | 8 Jahre | |
George Davy | M | 72 | 3 Jahre | |
Michael DesJardin | M | 66 | 9 Jahre | |
Kamran Hosseini | M | 59 | 2 Jahre | |
Erik D. Wiberg | M | - | 8 Jahre | |
Christopher Kurtz | M | 57 | - | |
Nacer E. Dean Abrouk | M | - | - | |
David Banks | M | - | 6 Jahre | |
Joel A. Fernandes | M | 54 | 3 Jahre | |
Carter J. King | M | 52 | 4 Jahre | |
Matthew J. Meyer | M | 54 |
Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 2 Jahre |
Joanne Quan | M | 60 | 3 Jahre | |
Nandan Oza | M | 61 | 15 Jahre | |
Mark A. Evashenk | M | - | 1 Jahre | |
Ronald P. Haak | M | - | 14 Jahre | |
George Tyson | M | - | 9 Jahre | |
Tetsuto Nagata | M | - |
Teikoku Pharma USA, Inc.
Teikoku Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Teikoku Pharma USA, Inc. develops and manufactures drugs. It provides patches, unit-dose jellies and liquids, creams, ointments, and other delivery products for pain management and cosmetic care. The company was founded by Masahisa Kitagawa and Ichiro Mori in 1997 and is headquartered in San Jose, CA. | - |
Kimberley Gaumer | F | - | 22 Jahre | |
Aron M. Knickerbocker | M | 54 | 1 Jahre | |
David Abraham | M | 58 | 2 Jahre | |
Carole Roth | F | - | 7 Jahre | |
Jeff Hargroves | M | 58 | 3 Jahre | |
Suneel Gupta | M | 66 | 12 Jahre | |
Kevin Brodbeck | M | - | 6 Jahre | |
Lawrence G. Hamel | M | 72 | 30 Jahre | |
Michael W. Ramsay | M | 67 | 2 Jahre | |
Padmanabh P. Bhatt | M | 66 | 5 Jahre | |
Daniel J. Levitt | M | 76 |
Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 2 Jahre |
Michael Miller | M | 67 | 4 Jahre | |
Detlef F. Albrecht | M | 63 | 10 Jahre | |
Steven Ketchum | M | 59 | 8 Jahre | |
Howard Rosen | M | 66 | 10 Jahre | |
Steve Cartt | M | 61 | 15 Jahre | |
Susan P. Rinne | F | 72 | 11 Jahre | |
Ahmed Hamdy | M | 59 | 2 Jahre | |
Joan E. Colligan | F | - | 4 Jahre | |
Samuel Saks | M | 69 | 2 Jahre | |
James W. Young | M | 79 | 5 Jahre | |
Robert M. Myers | M | 60 | 9 Jahre | |
Kin Hung Yu | M | 61 | 2 Jahre | |
Natalie L. McClure | M | 71 |
Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 3 Jahre |
Felix Theeuwes | M | 86 | 29 Jahre | |
Daniel Swisher | M | 61 | 9 Jahre | |
Matthew Fust | M | 59 | 6 Jahre | |
Carol A. Gamble | F | 71 | 12 Jahre | |
Ed F. Schnipper | M | 75 | 4 Jahre | |
Janne L. T. Wissel | F | 68 | 22 Jahre | |
Valerie Pierce | F | 61 | 5 Jahre | |
Peter K. Working | M | 75 | 2 Jahre | |
Asha Ramdas | F | - | - | |
Christopher Dammann | M | 54 | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 57 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Scott T. Shearer
- Persönliches Netzwerk